Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oncogene

Showing results (641-650 of 22,563) with videos related to

Pageof 2,257
Sort By:
Oncogene|May 29, 2007
Anti-idiotype antibodies in cancer treatmentA López-Díaz de Cerio, N Zabalegui, M Rodríguez-Calvillo, et al.
Oncogene|May 29, 2007
Rituximab therapy in malignant lymphomaB Coiffier
Oncogene|May 29, 2007
Rituximab-induced inhibition of antiapoptotic cell survival pathways: implications in chemo/immunoresistance, rituximab unresponsiveness, prognostic and novel therapeutic interventionsB Bonavida
Oncogene|May 29, 2007
The role of Gemtuzumab Ozogamicin in the treatment of acute myeloid leukemia patientsL Pagano, L Fianchi, M Caira, et al.
Oncogene|May 29, 2007
Daclizumab (anti-Tac, Zenapax) in the treatment of leukemia/lymphomaT A Waldmann
Oncogene|May 29, 2007
Novel antibodies as anticancer agentsI Zafir-Lavie, Y Michaeli, Y Reiter
Oncogene|June 5, 2007
Assessment of MLH1 promoter methylation in relation to gene expression requires specific analysisE Capel, J-F Fléjou, R Hamelin
Oncogene|June 5, 2007
Repression of Dmp1 and Arf transcription by anthracyclins: critical roles of the NF-kappaB subunit p65P Taneja, A Mallakin, L A Matise, et al.
Oncogene|June 5, 2007
Regulation of mitochondrial Smac/DIABLO-selective release by survivinG Ceballos-Cancino, M Espinosa, V Maldonado, et al.
Oncogene|June 5, 2007
KIT oncogenic signaling mechanisms in imatinib-resistant gastrointestinal stromal tumor: PI3-kinase/AKT is a crucial survival pathwayS Bauer, A Duensing, G D Demetri, et al.
Pageof 2,257

Showing results (641-650 of 22,563) with videos related to

Sort By:
Pageof 2,257
Oncogene|May 29, 2007
Anti-idiotype antibodies in cancer treatmentA López-Díaz de Cerio, N Zabalegui, M Rodríguez-Calvillo, et al.
Oncogene|May 29, 2007
Rituximab therapy in malignant lymphomaB Coiffier
Oncogene|May 29, 2007
Rituximab-induced inhibition of antiapoptotic cell survival pathways: implications in chemo/immunoresistance, rituximab unresponsiveness, prognostic and novel therapeutic interventionsB Bonavida
Oncogene|May 29, 2007
The role of Gemtuzumab Ozogamicin in the treatment of acute myeloid leukemia patientsL Pagano, L Fianchi, M Caira, et al.
Oncogene|May 29, 2007
Daclizumab (anti-Tac, Zenapax) in the treatment of leukemia/lymphomaT A Waldmann
Oncogene|May 29, 2007
Novel antibodies as anticancer agentsI Zafir-Lavie, Y Michaeli, Y Reiter
Oncogene|June 5, 2007
Assessment of MLH1 promoter methylation in relation to gene expression requires specific analysisE Capel, J-F Fléjou, R Hamelin
Oncogene|June 5, 2007
Repression of Dmp1 and Arf transcription by anthracyclins: critical roles of the NF-kappaB subunit p65P Taneja, A Mallakin, L A Matise, et al.
Oncogene|June 5, 2007
Regulation of mitochondrial Smac/DIABLO-selective release by survivinG Ceballos-Cancino, M Espinosa, V Maldonado, et al.
Oncogene|June 5, 2007
KIT oncogenic signaling mechanisms in imatinib-resistant gastrointestinal stromal tumor: PI3-kinase/AKT is a crucial survival pathwayS Bauer, A Duensing, G D Demetri, et al.
Pageof 2,257